Skip to content

Life Science

ISSN 2252-6277

6 papers in the library · 236 citations · publishing 1989-2023

Papers

Sort Most recent Most cited

Neurophilosophy: A Philosophical Analysis for Interpretation of fMRI to Replace the Commonsense Psychology

Life Science October 5, 2023 Amjad Sohail

For thinking, brain activity occurs, yet not every area of our brain is active when we think about various things. There are significant ramifications for cognitive psychology and neuroscience from functional brain areas. It should enable us to apply neurophilosophical theories to the brain. This review aims to draw attention to neurophilosophy and its focus on fundamental problems in...

Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine.

Life Science May 1, 2023 Miroslav Adzic, Iva Lukic, Milos Mitic et al.

Major depressive disorder (MDD) afflicts approximately 5 % of the world population, and about 30-50 % of patients who receive classical antidepressant medications do not achieve complete remission (treatment resistant depressive patients). Emerging evidence suggests that targeting opioid receptors mu (MOP), kappa (KOP), delta (DOP), and the nociceptin/orphanin FQ receptor (NOP) may yield...

Lasting effects of ketamine and isoflurane administration on anxiety- and panic-like behavioral responses in Wistar rats.

Life Science March 27, 2021 Máira Tereza Talma Chírico, Mariana Reis Guedes, Lucas Gabriel Vieira et al.

In clinical and laboratory practice, the use of anesthetics is essential in order to perform surgeries. Anesthetics, besides causing sedation and muscle relaxation, promote several physiological outcomes, such as psychotomimetic alterations, increased heart rate, and blood pressure. However, studies depicting the behavioral effect induced by ketamine and isoflurane are conflicting. In the...

Neurotoxicity of Methamphetamine and 3,4-methylenedioxymethamphetamine

Life Science July 24, 2013 Laura E. Halpin, Stuart A. Collins, Bryan K. Yamamoto 195 citations

Amphetamines are a class of psychostimulant drugs that are widely abused for their stimulant, euphoric, empathogenic and hallucinogenic properties. Many of these effects result from acute increases in dopamine and serotonin neurotransmission. Subsequent to these acute effects, methamphetamine and 3,4 methylenedioxymethamphetamine (MDMA) produce persistent damage to dopamine and serotonin nerve...

Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus

Life Science July 24, 2013 M. Angoa-Perez, Michael J. Kane, Nieves Herrera-Mundo et al. 41 citations

Aims Mephedrone is a stimulant drug of abuse with close structural and mechanistic similarities to methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA). Although mephedrone does not damage dopamine nerve endings it increases the neurotoxicity of amphetamine, methamphetamine and MDMA. The effects of mephedrone on serotonin (5HT) nerve endings are not fully understood, with some...

Dextromethorphan and sigma ligands: common sites but diverse effects.

Life Science 1989 J. Musacchio, M. Klein, P. Canoll

There is increasing evidence that sigma ligands and dextromethorphan (DM) bind to at least one common high-affinity site. DM and other antitussives do not produce psychotomimetic effects. This suggested that sigma ligands may produce their characteristic effects through another site, and prompted us to review critically the literature on the side effects of sigma opiates. Contrary to what is...